Paper Review Records
All Paper Review Records
21 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.
245
days
The deep learning framework Hist2Prot infers single-cell spatial proteomics from histology to predict biomarkers and clinical outcomes
Authors
Jiansong Fan; Sen Yang; Erqiang Hu; Jianhong An; Qiang Liu; Naijia Liu; Mingwei Ma; Michael Prystowsky; Tianxu Lv; Si Yong Yeo; Yuting Ren; Yuan Liu; Lihua Li; Yuan Li; Qi Sun; Pengjiang Qian; Le Lu; Wenjun Deng; Xiang Pan; Shanye YinShow moreShow less
Affiliations
1. School of Artificial Intelligence and Computer Science, Jiangnan University, Wuxi, China; 2. Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore, Singapore; 3. The PRC Ministry of Education Engineering Research Center of Intelligent Technology for Healthcare, Wuxi, China; 4. Ant Healthcare (AFU), Ant Group, Hangzhou, China; 5. Department of Pathology, Albert Einstein College of Medicine, Bronx, USA; 6. Einstein Pathology Single-Cell & Bioinformatics Laboratory, Bronx, USA; 7. Montefiore Einstein Comprehensive Cancer Center, Albert Einstein College of Medicine, Bronx, USA; 8. Institute of Biomedical Engineering and Instrumentation, Hangzhou Dianzi University, Hangzhou, China; 9. Department of Pathology, Fudan University Shanghai Cancer Center, Shanghai, China; 10. Department of Pathology, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Nanjing, China; 11. Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, USAShow moreShow less
430
days
A single-cell lung cancer atlas reveals cellular and molecular drivers of metastasis and clinical outcome
Authors
Philipp Jurmeister; Philipp Keyl; Liliana Harris Mochmann; Linda Bergmayr; Konstanze Schleich; Edgar Chimal Calderon; Fabian Engelhardt-Schott; Doreen Klingler; Dražen Papić; Janine Wolff; Rebecca Fritz; Julius Keyl; Sabine Merkelbach-Bruse; Alexander Quaas; Georg Schlachtenberger; Matthias Heldwein; Jens-Carsten Rückert; Gabriel Dernbach; Nils Reinmuth; Christian Grohé; Reinhard Büttner; David Horst; Nikolaj Frost; Patrick Nikolaus Harter; Klaus-Robert Müller; Simon Schallenberg; Frederick KlauschenShow moreShow less
Affiliations
1. Institute of Pathology, LMU Medizin, Ludwig-Maximilians-Universität München, Munich, Germany; 2. German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Munich partner site, Munich, Germany; 3. Institute of Pathology, Charité - Universitätsmedizin Berlin, Berlin, Germany; 4. BIFOLD – Berlin Institute for the Foundations of Learning and Data, Berlin, Germany; 5. Institute for Artificial Intelligence in Medicine, University Hospital Essen, Essen, Germany; 6. Institute of Pathology, University Hospital Essen, Essen, Germany; 7. Institute for Pathology, Faculty of Medicine, University Hospital Cologne, University of Cologne, Cologne, Germany; 8. Department of Cardiothoracic Surgery, University Hospital Cologne, Cologne, Germany; 9. Department of General, Visceral, Vascular and Thoracic Surgery, Charité - Universitätsmedizin Berlin (Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin and Berlin Institute of Health), Berlin, Germany; 10. Asklepios Lung Cancer Clinic, Gauting, Germany; 11. Evangelische Lungenklinik Berlin-Buch, Berlin, Germany; 12. German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Berlin partner site, Berlin, Germany; 13. Department of Infectious Diseases and Pulmonary Medicine, Charité - Universitätsmedizin Berlin (Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin and Berlin Institute of Health), Berlin, Germany; 14. Center for Neuropathology and Prion Research, Faculty of Medicine, Ludwig-Maximilians-University, Munich, Germany; 15. Machine Learning Group, Technical University of Berlin, Berlin, Germany; 16. Department of Mathematics and Computer Science, Technical University of Berlin, Berlin, Germany; 17. Department of Artificial Intelligence, Korea University, Seoul, South Korea; 18. MPI for Informatics, Saarbrücken, Germany; 19. Bavarian Cancer Research Center (BZKF), Munich partner site, Munich, GermanyShow moreShow less
215
days
Natural killer cell inflammatory circuits in antitumor immunity
Authors
Nicholas D. Huntington; Xiangpeng Meng; Michael Chopin; Rebecca B. DelconteShow moreShow less
Affiliations
1. Department of Biochemistry and Molecular Biology, Cancer and Immunity Programs, Biomedicine Discovery Institute, Monash University, Clayton, Australia; 2. Audax Biosciences, Moonee Ponds, Australia; 3. Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, Australia; 4. Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Australia; 5. Department of Medical Biology, University of Melbourne, Parkville, AustraliaShow moreShow less
422
days
Spatiotemporal control of CAR-T cell TNF release via tumor-targeted irradiation
Authors
Elham Masoumi; Paulina Walczak; Takemasa Tsuji; Vera Huzniakova; Byoung Hyuck Kim; Soumya Iyer; Edurne Luque; Agnes Julia Bilecz; Junko Matsuzaki; Christian F. Olortegui; Kunle Odunsi; Ralph R. Weichselbaum; Ainhoa ArinaShow moreShow less
Affiliations
1. Department of Radiation and Cellular Oncology and Ludwig Center for Metastasis Research, The University of Chicago, Chicago, USA; 2. University of Chicago Medicine Comprehensive Cancer Center, Chicago, USA; 3. Committee on Cancer Biology at the University of Chicago Biological Science Division, Chicago, USA; 4. Department of Obstetrics and Gynecology, University of Chicago, Chicago, USA; 5. School of Biochemistry, Biophysics and Biotechnology, Jagiellonian University, Krakow, Poland; 6. Department of Radiation Oncology, Seoul National University College of Medicine, SMG-SNU Boramae Medical Center, Seoul, South KoreaShow moreShow less
682
days
Basophils inhibit early lung metastasis by suppressing regulatory T cells
Authors
Bruno Torchia; Nadine Fournier; Simge Yücel; Morgane Fournier; Soroush Setareh; Hadi Esmaily; Yahya Mohammadzadeh; Joao Lourenco; Ali Ghasemi; Elodie Marcandalli; Luqing Li; Mehrnaz Mesdaghi; Shideh Namazi Bayegi; Camilo Faust; Anton M. Schule; Tommaso Scolaro; Marta Manco; Celine Wyser Rmili; Niki Ubags; Stacey D. Finley; Christophe von Garnier; Massimiliano Mazzone; Francisco J. Quintana; Michele De Palma; Nahal MansouriShow moreShow less
Affiliations
1. Swiss Institute for Experimental Cancer Research (ISREC), School of Life Sciences, Swiss Federal Institute of Technology in Lausanne (EPFL), Lausanne, Switzerland; 2. Agora Cancer Research Center, Lausanne, Switzerland; 3. Biomedical Data Science Facility (BDSF), Swiss Institute of Bioinformatics (SIB), Lausanne, Switzerland; 4. Department of Biotechnology, College of Sciences, University of Tehran, Tehran, Iran; 5. Department of Biotechnology, Institute of Bioprocess Science and Engineering, University of Nature Resources and Life Sciences, Vienna, Austria; 6. Department of Clinical Pharmacy, School of Pharmacy, Shahid Beheshti University of Medical Sciences, Tehran, Iran; 7. Clinical research development center, Imam Hossein Educational hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran; 8. Department of Allergy and Clinical Immunology, Mofid Children’s Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran; 9. Department of Allergy and Immunodeficiency, Massoud Medical Laboratory, Tehran, Iran; 10. Ann Romney Center for Neurologic Diseases, Brigham and Women’s Hospital, Harvard Medical School, Boston, USA; 11. Laboratory of Tumor Inflammation and Angiogenesis, Center for Cancer Biology, VIB, Leuven, Belgium; 12. Laboratory of Tumor Inflammation and Angiogenesis, Center for Cancer Biology, Department of Oncology, KU Leuven, Leuven, Belgium; 13. Division of Pulmonary Medicine, Department of Medicine, Lausanne University Hospital (CHUV), University of Lausanne (UNIL), Lausanne, Switzerland; 14. Alfred E. Mann Department of Biomedical Engineering, University of Southern California, Los Angeles, USA; 15. Broad Institute of MIT and Harvard, Cambridge, USA; 16. The Gene Lay Institute of Immunology and Inflammation, Brigham and Women’s Hospital, Harvard Medical School, Boston, USAShow moreShow less
128
days
Reframing cancer therapy through tumor plasticity
Authors
Akansha M. Shah; Bryan P. Marsh; Frederic J. de SauvageShow moreShow less
Affiliations
1. Department of Research Oncology, Genentech, South San Francisco, USAShow moreShow less
FAQ
How long does Nature Cancer take to review a manuscript?
As of 2026-11-18, CrushSCI has 21 complete review records for Nature Cancer. The fastest paper went from submission to acceptance in 35 days (GPNMB-directed CAR T cell therapy against MiT/TFE-family fusion-driven solid tumors, received 2026-04-29, accepted 2026-06-03); the slowest took 849 days. The average is 374.2 days and the median is 330 days.
Expert Matching · Case Demo
Turn Your Submission Goalsinto a Verifiable Journal Plan
Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.
